Zobrazeno 1 - 10
of 23
pro vyhledávání: '"Carla A. Talarico"'
Autor:
Bradley K. Ackerson, Katia J. Bruxvoort, Lei Qian, Lina S. Sy, Sijia Qiu, Julia E. Tubert, Gina S. Lee, Jennifer H. Ku, Ana Florea, Yi Luo, Radha Bathala, Julie Stern, Soon K. Choi, Harpreet S. Takhar, Michael Aragones, Morgan A. Marks, Evan J. Anderson, Cindy Ke Zhou, Tianyu Sun, Carla A. Talarico, Hung Fu Tseng
Publikováno v:
Human Vaccines & Immunotherapeutics, Vol 20, Iss 1 (2024)
ABSTRACTEmerging SARS-CoV-2 sublineages continue to cause serious COVID-19 disease, but most individuals have not received any COVID-19 vaccine for >1 year. Assessment of long-term effectiveness of bivalent COVID-19 vaccines against circulating subli
Externí odkaz:
https://doaj.org/article/2d84f244b16441a592c35ded5e599e4e
Autor:
Hung Fu Tseng, Bradley K. Ackerson, Lina S. Sy, Julia E. Tubert, Yi Luo, Sijia Qiu, Gina S. Lee, Katia J. Bruxvoort, Jennifer H. Ku, Ana Florea, Harpreet S. Takhar, Radha Bathala, Cindy Ke Zhou, Daina B. Esposito, Morgan A. Marks, Evan J. Anderson, Carla A. Talarico, Lei Qian
Publikováno v:
Nature Communications, Vol 14, Iss 1, Pp 1-11 (2023)
Abstract The bivalent (original and Omicron BA.4/BA.5) mRNA-1273 COVID-19 vaccine was authorized to offer broader protection against COVID-19. We conducted a matched cohort study to evaluate the effectiveness of the bivalent vaccine in preventing hos
Externí odkaz:
https://doaj.org/article/dc26e6eb256c44069443be1e36beb65a
Autor:
Hung Fu Tseng, Bradley K. Ackerson, Katia J. Bruxvoort, Lina S. Sy, Julia E. Tubert, Gina S. Lee, Jennifer H. Ku, Ana Florea, Yi Luo, Sijia Qiu, Soon Kyu Choi, Harpreet S. Takhar, Michael Aragones, Yamuna D. Paila, Scott Chavers, Carla A. Talarico, Lei Qian
Publikováno v:
Nature Communications, Vol 14, Iss 1, Pp 1-10 (2023)
In this study, the authors estimate the effectiveness of the mRNA-1273 (Moderna) vaccine for Omicron subvariants using data from the USA on ~31,000 cases and ~92,000 matched controls. They find that effectiveness against infection waned rapidly after
Externí odkaz:
https://doaj.org/article/fc5db9a261e244ce9f8b5ffdd6b33565
Autor:
Katia J. Bruxvoort, Lina S. Sy, Lei Qian, Bradley K. Ackerson, Yi Luo, Gina S. Lee, Yun Tian, Ana Florea, Harpreet S. Takhar, Julia E. Tubert, Carla A. Talarico, Hung Fu Tseng
Publikováno v:
The Lancet Regional Health. Americas, Vol 6, Iss , Pp 100134- (2022)
Summary: Background: Phase 3 trials found mRNA-1273 was highly effective in preventing COVID-19. We conducted a prospective cohort study at Kaiser Permanente Southern California (KPSC) to determine the real-world vaccine effectiveness (VE) of mRNA-12
Externí odkaz:
https://doaj.org/article/2480a17f26064f04903b9f83ca4b3743
Autor:
Tinevimbo Shiri, Marc Evans, Carla A. Talarico, Angharad R. Morgan, Maaz Mussad, Philip O. Buck, Phil McEwan, William David Strain
Publikováno v:
Vaccines, Vol 10, Iss 2, p 140 (2022)
The vaccination program is reducing the burden of COVID-19. However, recently, COVID-19 infections have been increasing across Europe, providing evidence that vaccine efficacy is waning. Consequently, booster doses are required to restore immunity le
Externí odkaz:
https://doaj.org/article/207a55762e4547f89156b53e1f284a69
Autor:
Tinevimbo Shiri, Marc Evans, Carla A. Talarico, Angharad R. Morgan, Maaz Mussad, Philip O. Buck, Phil McEwan, William David Strain
Publikováno v:
Vaccines, Vol 9, Iss 10, p 1180 (2021)
Debate persists around the risk–benefit balance of vaccinating adolescents and children against COVID-19. Central to this debate is quantifying the contribution of adolescents and children to the transmission of SARS-CoV-2, and the potential impact
Externí odkaz:
https://doaj.org/article/7385acdf065a4bbd8ef28a45a55f6e74
Autor:
Katherine E, Mues, Brenna, Kirk, Deesha A, Patel, Alice, Gelman, L Scott, Chavers, Carla A, Talarico, Daina B, Esposito, David, Martin, James, Mansi, Xing, Chen, Nicolle M, Gatto, Nicolas, Van de Velde
Publikováno v:
Vaccine. 40:6730-6739
Head-to-head studies comparing COVID-19 mRNA vaccine effectiveness in immunocompromised individuals, who are vulnerable to severe disease are lacking, as large sample sizes are required to make meaningful inferences.This observational comparative eff
Autor:
Ana Florea, Lina S Sy, Lei Qian, Bradley K Ackerson, Yi Luo, Julia E Tubert, Gina S Lee, Jennifer H Ku, Katia J Bruxvoort, Carla A Talarico, Sijia Qiu, Yun Tian, Hung Fu Tseng
Publikováno v:
Clinical Infectious Diseases. 76:252-262
Background We conducted a prospective cohort study at Kaiser Permanente Southern California to evaluate the relative vaccine effectiveness (rVE) of a booster dose vs 2-dose primary series of messenger RNA (mRNA)-1273 in immunocompetent individuals. M
Autor:
Jennifer H. Ku, Lina S. Sy, Lei Qian, Bradley K. Ackerson, Yi Luo, Julia E. Tubert, Gina S. Lee, Ana Florea, Katia J. Bruxvoort, Carla A. Talarico, Sijia Qiu, Yun Tian, Hung Fu Tseng
Publikováno v:
Vaccine.
Autor:
Hung Fu Tseng, Bradley K. Ackerson, Yi Luo, Lina S. Sy, Carla A. Talarico, Yun Tian, Katia J. Bruxvoort, Julia E. Tubert, Ana Florea, Jennifer H. Ku, Gina S. Lee, Soon Kyu Choi, Harpreet S. Takhar, Michael Aragones, Lei Qian
Publikováno v:
Nature Medicine. 28:1063-1071
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) Omicron (B.1.1.529) variant is highly transmissible with potential immune escape. We conducted a test-negative case–control study to evaluate mRNA-1273 vaccine effectiveness (VE) against